Qin Wang
Professor
Academic Appointment(s)
Medical College of Georgia
Department of Neuroscience and Regenerative Medicine
Medical College of Georgia
Department of Center for Biotechnology and Genomic Medicine
Administration
Department of The Graduate School
Education
-
Ph.D., Biology/Biological Sciences, G
University of Iowa, 1999
-
AMD, Microbiology and Immunology
Chinese Academy of Preventive, 1995
-
MB, Medicine
Beijing Medical College, 1992
Awards & Honors
-
Associate Editor
Current Alzheimer’s Research, 2023
-
Chair, NIH 2024/01 ZRG1 F03C-K (20) study section
NIH 2024/01 ZRG1 F03C-K (20) study section, 2023
-
AU/MCG Woman who inspires
Augusta University, MCG, 2022
-
Director, Alzheimer's Therapeutic program
Medical College of Gerogia, 2022
-
Neuropharmacology Executive Committee member
American Society for Pharmacology and Experimental Therapeutics, 2022
Courses Taught Most Recent Academic Year
Scholarship
Selected Recent Publications
- Priorities for research on neuromodulatory subcortical systems in Alzheimer's disease: Position paper from the NSS PIA of ISTAART, 2023
Journal Article, Academic Journal
- Understanding neuropsychiatric symptoms in Alzheimer's disease: challenges and advances in diagnosis and treatment., 2023
Journal Article, Academic Journal
- Diverse signaling mechanisms and heterogeneity of astrocyte reactivity in Alzheimer's disease., 2023
Journal Article, Academic Journal
- Activation of a novel α(2A)AR-spinophilin-cofilin axis determines the effect of α(2) adrenergic drugs on fear memory reconsolidation., 2022
Journal Article, Academic Journal
- Microglial NLRP3 inflammasome activates neurotoxic astrocytes in depression-like mice., 2022
Journal Article, Academic Journal
Research Interests
Dr. Qin Wang's research interests revolve around investigating cell surface receptor signaling and neuropharmacology in the context of brain physiology and disease pathology. Her laboratory employs state-of-the-art techniques, including CRISPR editing, multiomic analysis, super-resolution imaging, pharmacological and behavioral approaches, as well as humanized animal models, human postmortem tissues, and iPSC-derived brain cells, to elucidate the molecular and cellular mechanisms underlying Alzheimer's disease (AD) and complex behaviors. Furthermore, the lab explores the therapeutic potential of targeting these mechanisms for disease treatment, with the ultimate goal of translating their fundamental discoveries into novel clinical applications. One of the primary focuses of Dr. Wang's lab is AD, a multifaceted disease that involves numerous genetic and environmental factors. Her lab employs a multifaceted approach to address this complexity, with a particular emphasis on the following areas: 1) exploring the contribution of noradrenergic dysfunction to AD pathogenesis; 2) investigating alterations in endosomal trafficking in AD and the interactions between AD risk factors; 3) elucidating the role of astrocytic signaling and reactivity in AD progression; 4) examining the relationship between AD risk and cancer therapies, as well as congenital heart diseases; 5) developing treatments for AD by targeting neuronal hyperexcitability.
Department Service
-
Department Promotion and Tenure committee
2024 - Present
Role: Committee Member
-
Department recruitment committee
2024 - Present
Role: Committee Member
-
Neuroscience graduate program steering committee
2024 - Present
Role: Committee Member
-
Department Promotion and Tenure committee
2023 - Present
Role: Committee Member
-
Neuroscience graduate program steering committee
2023 - Present
Role: Committee Member
University Service
-
Project Mechanism Committee, Augusta University Laboratory Animal Services
2024 - Present
Role: Committee Member
-
Research Animal Services Advisory Group (RASAG)
2024 - Present
Role: Committee Member
-
Animal Research Advisory Committee
2023 - Present
Role: Committee Member
-
Internal grant review program
2023 - Present
Role: Committee Member
-
TRIBA new faculty recruitment
2022 - Present
Role: Other
Professional Service
-
NIH study section, NCATS special emphasis panel
2023 - Present
Role: Reviewer, Ad Hoc Reviewer
-
Current Alzheimer’s Research
2023 - Present
Role: Editor, Associate Editor
-
NIH 2024/01 ZRG1 F03C-K (20) study section
2023 - Present
Role: Chairperson
-
American Society for Pharmacology and Experimental Therapeutics, Neuropharmacology executive committee
2022 - Present
Role: Committee Member
-
Brain Science
2022 - Present
Role: Editorial Review Board Member
